Indeed, in NSCLC PC9 cells, DUSP1 overexpression abrogated long non-coding RNA CASC9-induced resistance to gefitinib and reduced ERK1/2 phosphorylation [74]. Here, DUSP1 is linked to non-small cell lung carcinoma.